Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Heather M. Selby
Antitumor Activity of the Polo-Like Kinase Inhibitor, TAK-960, Against Preclinical Models of Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
Exploration of Mutation and DNA Methylation of Polo-Like Kinase 1 (PLK1) in Colorectal Cancer
Open Journal of Pathology
A Cyclin-Dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer
PLoS ONE
Multidisciplinary
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Preclinical Evaluation of Biomarkers Associated With Antitumor Activity of MELK Inhibitor
Oncotarget
Oncology
LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer
Oncotarget
Oncology
Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor
International Journal of Oncology
Cancer Research
Oncology